Blue light destroyed all 64 Campylobacter strains tested in a UK study, including strains resistant to antibiotics. Scientists from the University of Reading and the Animal and Plant Health Agency reported the result after testing a technique called violet-blue photodynamic inactivation, or VB-PDI. Their conclusion is measured: the method shows promise, but more trials are needed before anyone can call it a processing-plant intervention.

The caveat matters. Laboratory killing is not commercial killing. The study tested strains, not production lines, throughput speeds or carcass surfaces at scale. What works on a bench may fail under the conditions of a plant that processes thousands of birds per hour.

Why Campylobacter commands attention

The pathogen is the most common cause of bacterial gastroenteritis worldwide. In 2024 and 2025, the UK recorded 70,000 laboratory-confirmed cases. That figure counts only confirmed cases, so the true burden is certainly higher.

Cooking kills the bacterium. The problem is what happens before cooking. Cross-contamination from handling raw meat is thought to be a major route of infection, which places the risk squarely in retail kitchens, foodservice prep areas and home kitchens rather than on the plate.

What did the study actually test?

The researchers exposed 64 different Campylobacter strains to violet-blue photodynamic inactivation. The technique uses light in the violet-blue range to inactivate bacteria.

The key finding:

• Every one of the 64 strains was killed by the treatment.
• Results held regardless of species.
• Results held regardless of antibiotic resistance profile.

That last point carries weight. Antibiotic-resistant strains often survive interventions that weaker strains do not, and a treatment that ignores resistance profiles entirely would simplify food safety planning for poultry processors.

What is not said

The study, as reported, does not state where the treatment would be applied in the supply chain. It does not give kill rates under commercial lighting conditions, on actual chicken skin, or at the speeds of an industrial line. It does not name a cost per unit or an equipment vendor. It does not commit to a timeline for field trials.

For operators, that gap is the story. Poultry processors already deploy chemical washes, surface treatments and temperature controls against Campylobacter. A light-based system would have to replace or supplement those measures at a price plants can justify, and no such economics appear in the findings.

The regulatory picture is also open. Any light-based intervention adopted in UK or EU processing plants would need approval and validation under food hygiene rules, a process the study does not address.

The scale of the problem

A single comparison frames the stakes. The UK logged 70,000 confirmed cases across two years, and Campylobacter remains the leading bacterial cause of gastroenteritis worldwide, despite decades of biosecurity measures, slaughterhouse controls and consumer campaigns on raw-chicken handling.

That persistence explains why an entirely physical intervention attracts interest. Light leaves no residue, requires no chemical handling and could, in principle, run continuously on a line.

In principle. The study's own authors frame the work as promising rather than proven, and the difference between those two words is measured in trials not yet run.

Further research will determine whether violet-blue photodynamic inactivation can move from the laboratory to the processing line, and at what cost to the poultry supply chain.